Hence, future longitudinal studies in larger patient cohorts are necessary to determine the impact of different classes of CFTR mutations, differences in treatment regimens and adherence to therapy, as well as other environmental and genetic factors on emphysema in patients with CF. Here, CFTR is linked to cystic fibrosis.